March 2016 FDA Recall Drug by Taro Pharmaceuticals U.s.a., Inc.
D-0950-2016 - Subpotent Drug
This Class III drug recall was voluntarily initiated by Taro Pharmaceuticals U.s.a., Inc. on March 31, 2016 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed in U.S. Including: CA, CT, MA, MD, NY, NJ, OK, TX, and WA and the recall is currently terminated.
Recall Number: D-0950-2016
Subpotent Drug
03-31-2016
06-08-2016
62,800 Tubes
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Taro Pharmaceuticals U.S.A., Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
U.S. Including: CA, CT, MA, MD, NY, NJ, OK, TX, and WA
06-06-2018
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
¿Topicort (desoximetasone) Cream USP, 0.05%, Packaged in 5 g Tubes, Professional Sample Only, Rx Only. Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: TaroPharma a division of Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC: 51672-5205-5.
Batch or Lot Expiration Information
Lot# A5192-18338, Expiry: 12/2016